Noreen McBrearty
Overview
Explore the profile of Noreen McBrearty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu Z, McBrearty N, Chen J, Tomar V, Zhang H, De Rosa G, et al.
Cell Metab
. 2024 Apr;
36(5):1164-1167.
PMID: 38604169
No abstract available.
2.
McBrearty N, Cho C, Chen J, Zahedi F, Peck A, Radaelli E, et al.
Mol Cancer Res
. 2022 Nov;
21(3):228-239.
PMID: 36378658
Implications: Loss of CH25H by pancreatic cancer cells may stimulate tumor progression and interfere with immunotherapies.
3.
Zhang H, Tomar V, Li J, Basavaraja R, Yan F, Gui J, et al.
Cancer Immunol Res
. 2022 Oct;
10(12):1490-1505.
PMID: 36255418
Fragility of regulatory T (Treg) cells manifested by the loss of neuropilin-1 (NRP1) and expression of IFNγ undermines the immune suppressive functions of Treg cells and contributes to the success...
4.
Lu Z, McBrearty N, Chen J, Tomar V, Zhang H, De Rosa G, et al.
Cell Metab
. 2022 Sep;
34(9):1342-1358.e7.
PMID: 36070682
Effector trogocytosis between malignant cells and tumor-specific cytotoxic T lymphocytes (CTLs) contributes to immune evasion through antigen loss on target cells and fratricide of antigen-experienced CTLs by other CTLs. The...
5.
Lu Z, Bae E, Verginadis I, Zhang H, Cho C, McBrearty N, et al.
Cancer Immunol Immunother
. 2022 Sep;
72(4):815-826.
PMID: 36063172
Immune suppressive factors of the tumor microenvironment (TME) undermine viability and exhaust the activities of the intratumoral cytotoxic CD8 + T lymphocytes (CTL) thereby evading anti-tumor immunity and decreasing the...
6.
McBrearty N, Arzumanyan A, Bichenkov E, Merali S, Merali C, Feitelson M
Neoplasia
. 2021 May;
23(5):529-538.
PMID: 33945993
Chronic infection with hepatitis B virus (HBV) is a major risk factor for the development of hepatocellular carcinoma (HCC). The HBV encoded oncoprotein, HBx, alters the expression of host genes...
7.
Hurwitz S, McBrearty N, Arzumanyan A, Bichenkov E, Tao S, Bassit L, et al.
Viruses
. 2021 Jan;
13(1).
PMID: 33467678
While treatment options are available for hepatitis B virus (HBV), there is currently no cure. Anti-HBV nucleoside analogs and interferon-alpha 2b rarely clear HBV covalently closed circular DNA (cccDNA), requiring...
8.
Cho C, Mukherjee R, Peck A, Sun Y, McBrearty N, Katlinski K, et al.
Oncogene
. 2020 Aug;
39(38):6129-6137.
PMID: 32807917
Activation of cancer-associated fibroblasts (CAFs) and ensuing desmoplasia play an important role in the growth and progression of solid tumors. Here we demonstrate that, within colon and pancreatic ductal adenocarcinoma...